Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
- Patricia B. Pavlinac*
- , Elizabeth T.Rogawski McQuade
- , James A. Platts-Mills
- , Karen L. Kotloff
- , Carolyn Deal
- , Birgitte K. Giersing
- , Richard A. Isbrucker
- , Gagandeep Kang
- , Lyou Fu Ma
- , Calman A. Maclennan
- , Peter Patriarca
- , Duncan Steele
- , Kirsten S. Vannice
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
18
Citations
(Scopus)